Caladrius SEC Filing | Lisata Therapeutics, Inc.

Filing date	Form	Description	View
Oct 7, 2009	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0001144204-09-051839.pdf 0001144204-09-051839.rtf 0001144204-09-051839.xls
Oct 7, 2009	EFFECT	EFFECT	View HTML 9999999995-09-002790.pdf 9999999995-09-002790.rtf 9999999995-09-002790.xls
Oct 6, 2009	S-4/A	Pre-effective amendment to an S-4 filing	View HTML 0001144204-09-051713.pdf 0001144204-09-051713.rtf 0001144204-09-051713.xls
Oct 6, 2009	8-K	Report of unscheduled material events or corporate event	View HTML 0001144204-09-051755.pdf 0001144204-09-051755.rtf 0001144204-09-051755.xls
Oct 6, 2009	UPLOAD	UPLOAD	View HTML 0000000000-09-056435.pdf
Oct 6, 2009	CORRESP	CORRESP	View HTML 0001144204-09-051750.pdf 0001144204-09-051750.rtf
Oct 5, 2009	3	Initial filing by director officer or owner of more than ten percent.	View HTML 0001144204-09-051563.pdf 0001144204-09-051563.rtf 0001144204-09-051563.xls
Oct 5, 2009	4	Statement of changes in beneficial ownership of securities	View HTML 0001144204-09-051565.pdf 0001144204-09-051565.rtf
Oct 2, 2009	CORRESP	CORRESP	View HTML 0001144204-09-051163.pdf 0001144204-09-051163.rtf
Sep 30, 2009	UPLOAD	UPLOAD	View HTML 0000000000-09-055274.pdf